about
Focal liver lesions: Practical magnetic resonance imaging approachMagnetic resonance imaging of pancreatitis: an updateHigh Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.Gastrointestinal imaging-practical magnetic resonance imaging approachPancreatitis-imaging approach.MR-PET of the body: Early experience and insights.Magnetic resonance imaging of the cirrhotic liver: An update.An overview of imaging techniques for liver metastases management.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.Radiologist income, receipts, and academic performance: an analysis of many nations.MR-PET co-registration in upper abdominal imaging: quantitative comparison of two different T1-weighted gradient echo sequences: initial observations.MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations.Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.Multiple focal nodular hyperplasia: MRI features.Self-reported gadolinium toxicity: A survey of patients with chronic symptoms.Surrogate arterial phase imaging using a long duration (≈1.5 min) radial acquisition T1-weighted sequence: an alternative in patients unable to breath-hold.Inter- and intra-individual comparative study of two gadolinium-based agents: A pilot study.Post-contrast T1-weighted sequences in pediatric abdominal imaging: comparative analysis of three different sequences and imaging approach.MRI Evaluation of cooperative and non-cooperative patients with non-traumatic acute abdominal pain - preliminary observations.High-resolution 3D-GRE imaging of the abdomen using controlled aliasing acceleration technique - a feasibility study.Lobulated margination of liver hemangiomas: Is this a definitive feature?T1 Signal-Intensity Increase in the Dentate Nucleus after Multiple Exposures to Gadodiamide: Intraindividual Comparison between 2 Commonly Used Sequences.Gadolinium deposition disease: Initial description of a disease that has been around for a whileQuantitative and qualitative comparison of 0.025 mmol/kg gadobenate dimeglumine for abdominal MRI at 1.5T and 3T MRI in patients with low estimated glomerular filtration rateHemiscrotal hematoma in the newborn-don't forget adrenal hemorrhageReply
P50
Q26799474-DE46888F-CF23-49D9-8233-75F69ABD679BQ26822012-B15466F7-FD0E-40CE-9A88-9935248F8F65Q30972928-3754D382-0009-4BC0-8263-770F4B1BD04AQ34101464-C05493F5-8E2B-4B8F-B2EA-9AE842833107Q38240879-1448CF66-72F7-49A7-A9FB-8282579A982EQ38367283-1769323F-8C6A-4832-83D7-FE9707DBE64AQ38408881-88A73236-DF44-408D-A1CD-93D8C23C76D8Q38594431-2CE98146-7223-40EE-A796-928769AFF0CAQ38667169-DFDEA1F2-43D2-46CB-A7A1-BCB6378D2091Q39961321-C89B0E4C-1669-48C7-AB3A-9332878AAA6CQ40918442-986642F7-5061-49F6-A824-CC54FB52DECFQ41022854-253C5DC2-DD9D-49B3-AC87-F4903B8184B7Q48881071-1A9392C6-BAD5-4B87-B2D3-0EEADA5E08D7Q49486870-89CDCFD9-1422-41A0-B7CA-7634CA4F0BBAQ50349261-911DAD3D-C9C0-40BA-8469-5C74CE6FE025Q50912552-768EBCF2-9A93-4118-A5AF-1AB6B2AC2859Q51053562-A7AB6D19-3BC9-4483-B889-FD02C767EE17Q51094967-CB5378B1-C28A-4CFE-BE10-37A412D134C7Q51505252-AFCD1C4F-8BCB-488D-B4AF-A4B2087A8131Q51636534-BEB9F499-7D5C-4D0D-A746-0AA6F4E8E8D8Q52983288-5A9C9F1A-8DF3-4537-A0C3-4E44BCDD3F25Q53133729-F97E93D9-50E1-459F-A5C4-D0CF660F010BQ57073311-62374488-2AC7-4D16-8235-2E1DDAD8ABC8Q86170974-9BA84657-5950-4A7C-8706-851590A5C013Q86597402-3CCA5E66-2038-4E15-AC6D-E07E001E0AD0Q87368337-58FF1525-BFB7-4F4A-A451-565A0B788AFB
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mamdoh AlObaidy
@ast
Mamdoh AlObaidy
@en
Mamdoh AlObaidy
@es
Mamdoh AlObaidy
@sl
type
label
Mamdoh AlObaidy
@ast
Mamdoh AlObaidy
@en
Mamdoh AlObaidy
@es
Mamdoh AlObaidy
@sl
prefLabel
Mamdoh AlObaidy
@ast
Mamdoh AlObaidy
@en
Mamdoh AlObaidy
@es
Mamdoh AlObaidy
@sl
P1053
F-6942-2014
P106
P1153
56189580000
P2038
Mamdoh_Alobaidy2
P31
P3829
P496
0000-0002-9081-0087
P569
2000-01-01T00:00:00Z